Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Exicure ( (XCUR) ) just unveiled an update.
Exicure announced that on February 6, 2026, board members Andy Yoo, Seung Ik Baik, and Aejin Hwang resigned from the Board of Directors, effective February 9, 2026, with the company stating the departures were not due to disagreements over operations, policies, or practices. The board simultaneously appointed Jung Kyu Ham, Jung Soo Kim, and Gyeung Seog Cheon as new directors in different board classes with terms expiring at the 2026, 2027, and 2028 annual meetings, set Mr. Cheon on the audit committee, approved annual retainers of $20,000 for the new directors, and authorized a one-time $20,000 cash payment to remaining directors Dongho Lee and Sangjin Yeo as well as to outgoing director Hwang.
On the executive side, Exicure reported that on February 6, 2026, Chief Executive Officer and President Andy Yoo and Chief Financial Officer and Secretary Seung Ik Baik tendered their resignations effective February 9, 2026, leaving both top officer roles temporarily vacant as the board has yet to name successors. In connection with his departure, Baik received a $150,000 separation payment, highlighting a significant leadership transition that may affect corporate governance and operational continuity until new executives are appointed.
The most recent analyst rating on (XCUR) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Exicure stock, see the XCUR Stock Forecast page.
Spark’s Take on XCUR Stock
According to Spark, TipRanks’ AI Analyst, XCUR is a Neutral.
The score is primarily constrained by weak financial performance (minimal revenue, large losses, and still-negative cash flow) and bearish technicals (below key moving averages with negative MACD). Offsetting these risks are signs of stabilization in 2024, including reduced cash burn and improved leverage.
To see Spark’s full report on XCUR stock, click here.
More about Exicure
Exicure, Inc. is a biotechnology company, as indicated by its use of a Board of Directors, executive roles such as Chief Executive Officer and Chief Financial Officer, and its history of filings with the U.S. Securities and Exchange Commission. The company operates within the life sciences sector and is governed by a classified board structure with staggered director terms aligned to annual shareholder meetings.
Average Trading Volume: 705,380
Technical Sentiment Signal: Sell
Current Market Cap: $25.69M
Learn more about XCUR stock on TipRanks’ Stock Analysis page.